NCT05527405 · ACTIVE NOT RECRUITING

Efficacy of Caregiver Training Program in Enhancing Caregiver and Patient Outcomes

This trial is testing a tablet-based visual scheduling app called MapHabit, paired with a structured caregiver training program, to see whether the combination reduces caregiver burden and improves daily functioning for people with Alzheimer's or related dementias. It is a Phase NA randomized controlled trial — meaning it is evaluating a behavioral and digital tool, not a drug, in a real-world care setting. Fifty patient-caregiver pairs will be followed for six months.

You may qualify if

  • Individual diagnosed with Alzheimer's disease or other related dementia (ADRD) in their mild to moderate stage of impairment
  • Participating caregiver of individual with dementia must be the primary caregiver
  • Proficient in English

You're excluded if

  • Individual not diagnosed with ADRD
  • Participating caregiver of individual with dementia is NOT the primary caregiver
  • Not proficient in English

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2025-10-02

View full record on ClinicalTrials.gov

All APOE4 clinical trials